股票 › VSTM
维拉斯特姆肿瘤 VSTM
美股市值排名 #3177
$8.41 −$0.97 (-10.34%)
休市 · Nov 7, 9:50 pm ET · 最新盘后价 $8.41 0.00%
开盘$8.66
昨收$9.38
当日区间$7.72 – $8.86
成交量7.04M
市值$1.06B
市盈率（TTM）–
股息率–
财报
财报日平均波动±9.3%近15次财报
收涨次数8 / 1553% 的概率
最佳反应+19.9%
最差反应-28.0%
每次财报后次日股价变动
| 季度 | 财报日期 | 时段 | 隐含波动 | 实际波动 | 较隐含波动 |
|---|---|---|---|---|---|
| 2026/Q2 | 6 Aug 2026 | After Market | ±24.9% | +14.04% | 符合区间 |
| 2026/Q1 | 7 May 2026 | After Market | ±24.5% | -13.60% | 符合区间 |
| 2025/Q4 | 4 Mar 2026 | None | ±26.7% | +5.85% | 符合区间 |
| 2025/Q3 | 4 Nov 2025 | After Market | ±32.6% | +3.16% | 符合区间 |
| 2025/Q2 | 7 Aug 2025 | After Market | ±25.1% | +19.93% | 符合区间 |
| 2019/Q3 | 29 Oct 2019 | After Market | – | -13.60% | – |
| 2019/Q2 | 1 Aug 2019 | After Market | – | -11.95% | – |
| 2019/Q1 | 9 May 2019 | After Market | – | -28.04% | – |
| 2018/Q4 | 12 Mar 2019 | After Market | – | +3.40% | – |
| 2016/Q4 | 23 Mar 2017 | After Market | – | +9.93% | – |
| 2016/Q3 | 7 Nov 2016 | None | – | +0.00% | – |
| 2015/Q4 | 3 Mar 2016 | Pre Market | – | +13.49% | – |
| 2013/Q4 | 6 Mar 2014 | Pre Market | – | -0.28% | – |
| 2012/Q4 | 27 Mar 2013 | Pre Market | – | +0.10% | – |
| 2011/Q4 | 14 Mar 2012 | Pre Market | – | -1.79% | – |
"隐含波动"指财报发布前期权市场定价的预期波幅。"波动"指财报发布后首个交易日的股价变化。
基本面
最新报告季度：Q2, ended Jun 2026
营收$40.08M+1,775.4% YoY
营业利润-$32.71M+25.3% YoY
净利润-$34.67M-33.7% YoY
摊薄每股收益-$0.35+43.5% YoY
自由现金流-$43.91M-34.4% YoY
经营现金流-$43.91M
营收，近8个季度
净利润，近8个季度
盈利能力与资产负债表
毛利率86.4%
营业利润率-182.6%
净利率-231.6%
净资产收益率-471.2%
资产收益率-100.7%
投入资本回报率-160.4%
流动比率2.25
负债/资产比率75.8%
现金及投资$136.35M
总负债$83.84M
净现金（净负债）$52.52M
暂无评论——快来第一个聊聊 VSTM。
登录后参与讨论。